These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


205 related items for PubMed ID: 7159211

  • 21. In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis.
    Esposito S, Gupta A, Thadepalli H.
    Drugs Exp Clin Res; 1987; 13(8):489-92. PubMed ID: 3428131
    [Abstract] [Full Text] [Related]

  • 22. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates.
    Oteo J, Aracil B, Alós JI, Gómez-Garcés JL.
    J Antimicrob Chemother; 2000 May; 45(5):691-3. PubMed ID: 10797095
    [Abstract] [Full Text] [Related]

  • 23. Bacteroides fragilis group: trends in resistance.
    Fille M, Mango M, Lechner M, Schaumann R.
    Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
    [Abstract] [Full Text] [Related]

  • 24. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A, Pawłowska J, Sawicka-Grzelak A, Luczak M.
    Med Dosw Mikrobiol; 2004 Feb; 56(3):245-53. PubMed ID: 15773501
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In-vitro antibiotic susceptibility and molecular analysis of anaerobic bacteria isolated in Cape Town, South Africa.
    Koch CL, Derby P, Abratt VR.
    J Antimicrob Chemother; 1998 Aug; 42(2):245-8. PubMed ID: 9738844
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.
    Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Goldstein EJ, Finegold SM, Harrell LJ, Hecht DW, Jenkins SG, Pierson C, Venezia R, Rihs J, Gorbach SL.
    Clin Infect Dis; 2002 Sep 01; 35(Suppl 1):S126-34. PubMed ID: 12173121
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Emergence of metronidazole-resistant Bacteroides fragilis, India.
    Chaudhry R, Mathur P, Dhawan B, Kumar L.
    Emerg Infect Dis; 2001 Sep 01; 7(3):485-6. PubMed ID: 11384542
    [No Abstract] [Full Text] [Related]

  • 34. In vitro antibacterial activity of cefotetan against Bacteroides fragilis group clinical isolates.
    Menozzi M, Avanzini P, Lecchini R, Bigi M, Chezzi C.
    Chemioterapia; 1987 Jun 01; 6(2 Suppl):88-91. PubMed ID: 3509541
    [No Abstract] [Full Text] [Related]

  • 35. Susceptibility testing of anaerobic bacteria. Regression lines for six antibiotics determined with and without prediffusion.
    Jansen JE, Bremmelgaard A.
    APMIS; 1991 Aug 01; 99(8):711-20. PubMed ID: 1859644
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.
    Dornbusch K, Olsson-Lijequist B, Nord CE.
    J Antimicrob Chemother; 1980 Mar 01; 6(2):207-16. PubMed ID: 6966626
    [No Abstract] [Full Text] [Related]

  • 40. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
    Toprak NU, Yağci A, Celik C, Cakici O, Söyletir G.
    Mikrobiyol Bul; 2005 Apr 01; 39(2):145-52. PubMed ID: 16128024
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.